Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Reports 7 Percent Increase in Preliminary Q1 Revenues

NEW YORK (GenomeWeb) – Hologic said today that it expects to report total revenues of $653 million for its fiscal first quarter ending Dec. 31, 2014.

The preliminary revenues represent a 7 percent increase over the prior-year period and exceed the company's previous quarterly revenue guidance of $625 million to $635 million. The projected revenues also beat consensus analyst estimates of $631 million for the quarter.

Hologic estimated a 6 percent increase in revenues for its Diagnostics business segment in the quarter, to $304 million. It projected $242 million in revenue for its Breast Health segment, which would be a 7 percent increase over the comparable period in 2013; $84 million in GYN Surgical revenue, also a 7 percent bump; and $22 million in Skeletal Health revenue, a 5 percent increase.   

Hologic also said today that it voluntarily prepaid $300 million of principal on a Term Loan B facility in December.

The company will release its full financial results for its first fiscal quarter on Jan. 28. 

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.